Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer
Zhengqi Cao(Shanghai Chest Hospital), Ziming Li(Shanghai Chest Hospital), Jing Sun(The University of Texas MD Anderson Cancer Center), Li Lu(Guangdong Pharmaceutical University), Anni Wang(Shanghai Chest Hospital), Jia Huang(Shanghai Chest Hospital), Zhouwenli Meng(Shanghai Chest Hospital), Yu Tian(Shanghai Chest Hospital), Li J(Johnson & Johnson (United States)), Shun Lu(Shanghai Jiao Tong University), Lixuan Chen(Shanghai Chest Hospital), Jingze Wang(Shanghai Chest Hospital)
Cited by 19
Related Papers
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|944
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
|Proceedings of the National Academy of Sciences|1985|522
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2022|255
Guanidine Hydrochloride Can Induce Amyloid Fibril Formation from Hen Egg-White Lysozyme
|Biomacromolecules|2004|223
Novel nanocomposites from spider silk–silica fusion (chimeric) proteins
|Proceedings of the National Academy of Sciences|2006|207